Cheyne Capital Management (UK) LLP - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2020$15,527,000
+606.1%
423,306
+343.6%
10.49%
+363.1%
Q1 2020$2,199,000
-28.5%
95,426
-9.2%
2.27%
+21.5%
Q4 2019$3,077,000
-49.9%
105,100
-54.3%
1.86%
-51.9%
Q3 2019$6,146,000
+182.8%
230,100
+170.7%
3.88%
+146.0%
Q2 2019$2,173,00085,0001.58%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders